have demonstrated that the quantitative determination of mRNA expression of KRT7 in the peripheral blood of patients suffering from lung cancer is a highly sensitive technique for the molecular detection of circulating tumor cells (CTCs) that closely resemble A549 cells originating from lung adenocarcinoma (AC) (21). This evidence concerns the gene KRT7 and lung carcinoma.